Ptc Therapeutics Inc (PTCT)

Cost of Revenue

$180.19M

TTM · Period ending: · USD

PTCT logo

PTCT Cost of Revenue

Latest reported$180.19M
PTCT TTM Cost of Revenue (-$5.17M → $180.19M)
High-resolution chart · PNG

PTCT cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ptc Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
180,187,000
171,686,000
156,520,000
156,504,000
51,413,000
55,520,000
57,398,000
147,407,000
146,052,000
143,256,000
142,660,000
47,261,000
51,779,000
48,687,000
44,678,000
43,112,000
35,640,000
33,359,000
32,328,000
27,887,000
26,015,000
23,961,000
18,942,000
17,598,000
15,937,000
13,844,000
12,135,000
12,354,000
12,640,000
12,001,000
12,670,000
11,343,000
9,633,000
7,819,000
4,813,000
27,590,000
57,404,000
85,473,000
116,833,000
126,670,000
125,914,000
125,277,000
121,816,000
113,639,000
101,764,000
91,887,000
79,838,000
67,987,000
63,108,000
59,507,000
54,875,000
39,133,445
24,095,115
7,862,351
-5,166,985
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.